1. Home
  2. CLDX vs NTB Comparison

CLDX vs NTB Comparison

Compare CLDX & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$29.00

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Bank of N.T. Butterfield & Son Limited (The) Voting

NTB

Bank of N.T. Butterfield & Son Limited (The) Voting

HOLD

Current Price

$50.99

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
NTB
Founded
N/A
1858
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
CLDX
NTB
Price
$29.00
$50.99
Analyst Decision
Strong Buy
Hold
Analyst Count
10
4
Target Price
$44.50
$53.75
AVG Volume (30 Days)
813.3K
135.7K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
3.90%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,743,000.00
N/A
Revenue This Year
$97.61
$0.88
Revenue Next Year
$252.01
$4.21
P/E Ratio
N/A
$9.64
Revenue Growth
87.78
N/A
52 Week Low
$14.40
$34.86
52 Week High
$31.31
$55.84

Technical Indicators

Market Signals
Indicator
CLDX
NTB
Relative Strength Index (RSI) 63.68 44.50
Support Level $24.70 $43.75
Resistance Level $30.50 $51.72
Average True Range (ATR) 1.52 1.52
MACD 0.78 -0.29
Stochastic Oscillator 77.87 21.55

Price Performance

Historical Comparison
CLDX
NTB

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.

Share on Social Networks: